(Q74620017)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12183168%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

review article

1 reference

title

Immunotherapy of insulin-dependent diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12183168%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

Emma L Masteller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12183168%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Jeffrey A Bluestone

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12183168%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 October 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12183168%20AND%20SRC:MED&resulttype=core&format=json

Current Opinion in Immunology

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12183168%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12183168%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

652-659

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12183168%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12183168%20AND%20SRC:MED&resulttype=core&format=json

Cyclosporine in recent onset type I diabetes mellitus. Effects on islet beta cell function. Miami Cyclosporine Diabetes Study Group

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Tolerance to islet autoantigens in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

T cell inactivation and cytokine deviation promoted by anti-CD3 mAbs

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Humanized, nonmitogenic OKT3 antibody, huOKT3 gamma(Ala-Ala): initial clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Nonmitogenic anti-CD3 monoclonal antibodies deliver a partial T cell receptor signal and induce clonal anergy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

The Src family kinase Fyn mediates signals induced by TCR antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Multiple immuno-regulatory defects in type-1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Regulating the immune response to transplants. a role for CD4+ regulatory cells?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Epitope spreading in immune-mediated diseases: implications for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Peptide therapy for diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Effects of insulin in relatives of patients with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Antigen based therapies to prevent diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Detection of GAD65-specific T-cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Clonal selection, clonal senescence, and clonal succession: the evolution of the T cell response to infection with a persistent virus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Antigen-specific blockade of T cells in vivo using dimeric MHC peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Enzymatically mediated engineering of multivalent MHC class II-peptide chimeras

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Induction of tolerance in experimental autoimmune myasthenia gravis with solubilized MHC class II:acetylcholine receptor peptide complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Regulation of encephalitogenic T cells with recombinant TCR ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Potent T cell activation with dimeric peptide-major histocompatibility complex class II ligand: the role of CD4 coreceptor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Antigen-specific signaling by a soluble, dimeric peptide/major histocompatibility complex class II/Fc chimera leading to T helper cell type 2 differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Anergy induction by dimeric TCR ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

A single-chain class II MHC-IgG3 fusion protein inhibits autoimmune arthritis by induction of antigen-specific hyporesponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide-MHC class II chimera

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

Progression of autoimmune diabetes driven by avidity maturation of a T-cell population

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900375-8

7 January 2021

10.1016/S0952-7915(02)00375-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12183168%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference